OxSonics Limited Secures £2.1m Biomedical Catalyst Award

Oxford, UK – 16 June 2014 OxSonics Limited (“OxSonics”), a University of Oxford spin-out company developing a new generation of ultrasound-based medical devices, today announced it has successfully secured a major £2.1 million Biomedical Catalyst award from the UK’s innovation agency, the Technology Strategy Board. OxSonics was established in July 2013 to develop and commercialise […]